Ubiquitination of MEIS1 by MDM2 serves as a switch for p53 stabilization and DNA damage response activation
Open Access
- 14 March 2026
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 33 (11) , 2220-2235
Abstract
Targeting MDM2 by disrupting its interaction with p53 or inhibiting its E3 ligase activity is a promising strategy to restore p53 functionality. However, achieving anticancer efficacy while minimizing dose-limiting toxicities remains a significant challenge. Moreover, MDM2 also ubiquitinates various non-p53 targets, complicating its therapeutic targeting. In this study, we demonstrate that MDM2 directly facilitates K48-linked polyubiquitination of MEIS1 at K178, leading to its proteasomal degradation. Notably, MEIS1 forms a non-competitive ternary complex with MDM2 and p53, effectively promoting ubiquitin transfer to itself and preventing p53 ubiquitination. The MEIS1 K178R mutant, which is deficient in ubiquitination, fails to suppress MDM2-mediated p53 ubiquitination, demonstrating a mechanistic link between MEIS1 self-ubiquitination and p53 stabilization. Furthermore, MDM2-mediated MEIS1 ubiquitination is a prerequisite for p53 activation in the DNA damage response. Importantly, a MEIS1-derived peptide, which mimics the MDM2-mediating ubiquitination motif, enhances both MEIS1 and p53 stability, suppresses cell proliferation and tumor growth. Collectively, our findings identify MEIS1 as a molecular decoy that competes for ubiquitin transfer to protect p53 and highlight that MEIS1 ubiquitination could be a novel therapeutic target for reactivating p53-dependent tumor suppression.Keywords
Funding Information
- National Natural Science Foundation of China (82173376)
- National Natural Science Foundation of China (82372711)
- National Natural Science Foundation of China (82303495)
This publication has 37 references indexed in Scilit:
- Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3Blood, 2010
- The DNA-damage response in human biology and diseaseNature, 2009
- The first 30 years of p53: growing ever more complexNature Reviews Cancer, 2009
- HIPK2 Regulation by MDM2 Determines Tumor Cell Response to the p53-Reactivating Drugs Nutlin-3 and RITACancer Research, 2009
- p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of SlugNature Cell Biology, 2009
- Autophagy and the ubiquitin-proteasome system: Collaborators in neuroprotectionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2008
- Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in transCell Death & Differentiation, 2008
- MEIS and PBX homeobox proteins in ovarian cancerEuropean Journal of Cancer, 2007
- p53 modulation of the DNA damage responseJournal of Cellular Biochemistry, 2006
- The role of the MEIS homeobox genes in neuroblastomaCancer Letters, 2003